T0	Outcomes 0 27	Safety and pharmacokinetics
T1	Outcomes 791 822	the safety and pharmacokinetics
T2	Outcomes 1097 1120	The mean FVIIa activity
T3	Outcomes 1231 1260	The pharmacokinetics of N7-GP
T4	Outcomes 1312 1325	investigated.
T5	Outcomes 1326 1385	No serious adverse events (including thromboembolic events)
T6	Outcomes 1401 1432	The frequency of adverse events
T7	Outcomes 1483 1523	No neutralizing antibodies against N7-GP
T8	Outcomes 1539 1561	A pharmacologic effect
T9	Outcomes 1635 1660	the mean prothrombin time